You are here

  • Home
  • Archive
  • Volume 69, Issue 2
  • Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms

Article info

Article menu

Download PDFPDF

Original article
Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms
Free

Authors

  • Jacques A J Malherbe School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Kathryn A Fuller School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Ayesha Arshad School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Jyoti Nangalia Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Giuliana Romeo School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Sara L Hall School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Katie S Meehan School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Belinda Guo School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Rebecca Howman School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Wendy N Erber School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia PathWest Laboratory Medicine, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Wendy N Erber, School of Pathology and Laboratory Medicine (M504), The University of Western Australia: 35 Stirling Highway, Crawley, WA 6009, Australia; wendy.erber{at}uwa.edu.au
View Full Text

Citation

Malherbe JAJ, Fuller KA, Arshad A, et al
Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms
Journal of Clinical Pathology 2016;69:155-163.

Publication history

  • Received June 1, 2015
  • Revised July 17, 2015
  • Accepted July 22, 2015
  • First published August 19, 2015.
Online issue publication 
February 23, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/